Jingzeng Du
Papers
1
Total Citations
3
H-Index
1
About
Dr. Jingzeng Du is a urological researcher whose work centers on improving early cancer detection through accessible biomarkers. His most cited study investigates the predictive value of the neutrophil-to-lymphocyte ratio (NLR)—a simple, inexpensive blood test—in diagnosing early prostate cancer among men undergoing robotic transperineal prostate biopsy. By correlating preoperative full blood counts with histology results, Dr. Du’s research offers a potential, non-invasive tool to stratify biopsy candidates, reducing unnecessary procedures and enhancing diagnostic precision. Although his work has garnered initial citations, its clinical relevance is growing as the medical community seeks cost-effective screening adjuncts. Dr. Du’s focus on integrating routine laboratory data into urological decision-making highlights a pragmatic approach to oncology, aiming to translate basic inflammatory markers into actionable insights for early cancer detection. His contributions underscore a commitment to bridging laboratory science and bedside practice, with implications for improving patient outcomes in prostate cancer diagnosis.
Research Focus
Key Achievements
Top Papers
- 1